Læknablaðið

Ukioqatigiit

Læknablaðið - 01.06.1973, Qupperneq 39

Læknablaðið - 01.06.1973, Qupperneq 39
LÆRKiABLAÖIÐ 11ð milk caused no paratyphoid fever. Had pasteurization failed, the outbreak would probably have been much more v/ide- spread and many times as large. That story shows not only that there is stiil need for vigilance but also that our guarri is normally effective. Every year in Britain there are out- breaks of food poisoning, sometimes only family outbreaks, sometimes affecting larger numbers through communal feed- ing. An unnoticed staphyloccccal infection on the hand of a worker in some whole- sale food establishment can be the origin of a substantial outbreak, of food produced wholesaie is affected. Clostridial infection of a batch of poultry, perhaps inadequate- ly cooked and eaten cold after too siow cooling, can eaually produce an outbreak of this kind. We have much still to do in applying the lessons we already know to the better protection of food, but haa we not already done a very great deal, the growth of communal feeding and the present wholesale and retail systems of food distribution in Britain would certain- ly have produced much more wide-spread harm. There has recently been much public debate about the dangers of cholera in Western Europe. In countries with a sound sanitary organisation those dangers are not serious. There could be local out- breaks, but, given reasonable protection of water supplies, not the kind of major in- cident that has occurred so often in tropic- al countries. What can happen without sanitation has been all too sadly demon- strated in Africa in the last vear. But the solution there is essentially one of sanitarv engineering. The relatively secure en- vironment that our ancestors have pro- vided for us has not not been provided by the peoples of Africa and Asia or bv those who should help them. There must one day be a huge investment in securing those populations too against the diair- hceal diseases which used to be the scourge of Europe in former centuries. They are still sufficiently prevalent for British holi- day makers to bving back from Southern Europe, nearly half of all the new in- fections reported in Britain each year from typhoid, paratyphoid and poliomye- litis. Except for the last, these are not diseases we are yet able to prevent with certainty bv immunisation or vaccination. I look with envy at your record of total freedom from tvphoid for over a quarter of a century — but your people too go to Southern Europe. The first programme of active immunisa- tion against disease was the practice, used in a limited way, of variolation or infec- tion with smallpox itself at a time when least harm was expected. 175 years ago last May, Edward Jenner, a doctor prac- ticing in Gloucestershire, first artificially inoculated a boy with vaccinia. From that grew the world wide use of vaccination as a primary method of preventing small- pox. Last month the Expert Committee on Vaccination in Britain advised that routine vaccination of infants was no longer justi- fiable because the WHO programme for eradication of smallpox has made such pro- gress that the risk of introducing smallpox to Britain is now only a small fraction of what it once was and may be almost eliminated within perhaps 3 years, while vaccination causes us from 3 to 5 deaths every year. This has been a twofold triumph over certain human infections in the last 20 years. Primary immunisation against diphtheria, tetanus, poliomyelitis, measles, rubella, whooping cough and tuberculosis is now general in Britain and many other countries. The protection which can be conferred against diphtheria, tetanus, measles and poliomyelitis is virtually com- plete. Considerable protection can be given against tuberculosis by BCG. The reli- ability of the protection against whooping cough is less certain but is probably con- siderable and rubella vaccine has been in use too short a time for reliable conclus- ions. It must be a continuing objective of preventive medicine to maintain that prim- ary protection, as it would still be in Britain to vaccinate against smallpox if there were not a real prospect that small- pox would be eradicated. There could be other vaccines to come, for instance against mumps and more important in- fective hepatitis. We can hope to control
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72

x

Læknablaðið

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.